Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Core Insights - Oncocyte Corp. has appointed Dr. Paul Billings as Consulting Chief Medical Officer to support strategic and clinical goals [2][3] - Dr. Billings is a pioneer in genomics and precision medicine with over 40 years of experience in academia, government, and biotechnology [3][5] - The appointment is expected to enhance Oncocyte's capabilities in regulatory support, reimbursement, business development, and strategic partnerships [6] Company Overview - Oncocyte is a diagnostics technology company focused on providing clarity and confidence to physicians and patients through its tests [7] - Key products include VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™, which are designed for organ transplantation monitoring and cancer treatment efficacy [7][8] - The company aims to improve patient care by enabling testing closer to patients with quality and favorable economics [4]